This podcast focuses on best practices in the management of atopic dermatitis in pediatric patients, specifically highlighting education that can be provided to patients and parents to maximize the success of treatment.
Our interview subject is Dr. Lawrence Schachner, Chair and Professor Emeritus of Dermatology and Director of the Division of Pediatric Dermatology at the University of Miami, Miller School of Medicine in Miami, FL.
Dr. Larry Schachner chaired an advisory board with doctors Latanya T. Benjamin, MD, Clarence de Belilovsky, MD, Alana F. Bree, MD, Kaitlyn M. Enright, MSc, PhD candidate, Adelaide A. Hebert, MD, Janice Pelletier, MD , Ayleen Pinera-Llano, MD, and Amy Theos, MD. Together they worked on issues and prepared a paper on recommendations for algorithms in the treatment of atopic dermatitis, which helped form this podcast. We acknowledge their contributions and work.
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
Dupilumab safe, effective for up to 1 year for atopic dermatitis in infants, preschool children
May 3rd 2024According to new study data presented at the 2024 Pediatric Academic Societies Meeting, dupilumab (dupixent; Sanofi and Regeneron) demonstrated positive safety and efficacy results for up to 1 year in infants and preschool-age children with atopic dermatitis.